Nucleoside News and Research

RSS
Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

Rice University researchers model a key mechanism by which DNA replicates

Rice University researchers model a key mechanism by which DNA replicates

Is cannabidiol effective against COVID-19?

Is cannabidiol effective against COVID-19?

Remdesivir resistance in renal transplant patients with long COVID-19

Remdesivir resistance in renal transplant patients with long COVID-19

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

Marine bioactive compounds against SARS-CoV-2

Marine bioactive compounds against SARS-CoV-2

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

Artificial circular RNAs found to bypass cellular antiviral responses

Artificial circular RNAs found to bypass cellular antiviral responses

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Exploring biomedical literature and clinical trial records to identify new drug combinations for COVID-19 treatment

Exploring biomedical literature and clinical trial records to identify new drug combinations for COVID-19 treatment

Combating COVID cytokine storm with targeted nucleic acid therapies

Combating COVID cytokine storm with targeted nucleic acid therapies

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates

Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates